Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell IDEXX Laboratories, Inc. (IDXX) – IDEXX Laboratories, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

IDEXX Laboratories (IDXX) trades at $571.71, up 0.38% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company demonstrates strong profitability with a 24.62% net income margin and 66.2% ROE, supported by consistent earnings beats in recent quarters. Revenue growth trends upward, reaching $3.9 billion in 2024, with robust cash flow from operations of $929 million. Recent news highlights product innovations like the UK launch of a canine lymphoma detection panel and institutional buying interest.
Outlook remains positive given analyst consensus of a $751 price target and 59% buy ratings, though high valuation multiples (P/E 44.15) and technical bearishness pose near-term risks. Earnings growth and diagnostic market expansion offer upside, while debt levels and competitive pressures require monitoring for long-term investors.
Read full analysis

Key Stats

  • Market Cap
    $45.65B
  • Sector
    Health
  • 3M Drawdown
    -23.13%
  • Enterprise Value
    $46.45B
  • Dividend Yield
    -
  • Typical Hold Time
    42 days
$595.99
52W Low: $361.04
08 Apr 2025
52W High: $766.68
25 Nov 2025

IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $45.65B, with an enterprise value of $46.45B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $361.04 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -23.13%, reflecting recent price volatility. IDEXX Laboratories, Inc. offers a dividend yield of -. On average, investors hold IDEXX Laboratories, Inc. for approximately 42 days, indicating typical investor behavior on the platform.

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.


Technical Indicators
|
|
|
Overall Summary
Bearish (1)Neutral (11)Bullish (15)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $45.65B
  • Sector
    Health
  • 3M Drawdown
    -23.13%
  • Enterprise Value
    $46.45B
  • Dividend Yield
    -
  • Typical Hold Time
    42 days
$595.99
52W Low: $361.04
08 Apr 2025
52W High: $766.68
25 Nov 2025

IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $45.65B, with an enterprise value of $46.45B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $361.04 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -23.13%, reflecting recent price volatility. IDEXX Laboratories, Inc. offers a dividend yield of -. On average, investors hold IDEXX Laboratories, Inc. for approximately 42 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!